Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of a herbal combination in women with overactive bladder syndrome
DRKS00000268Phase 4Terminated
- Sponsor
- Haleon
- Start
- Jan 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Granu Fink femina in overactive bladder (OAB) (2 arms), sponsored by Haleon. Started Jan 2010; status: terminated.
02
Drugs
Granu Fink femina
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on DRKS00000268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000268.